CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Uveal Melanoma
Related studies linked through entity extraction aliases.
A Study of PLX2853 in Advanced Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study in Subjects With Small Primary Choroidal Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vorinostat in Patients With Class 2 High Risk Uveal Melanoma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis
- Status
- COMPLETED
- Phase
- PHASE2
Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)
- Status
- COMPLETED
- Phase
- NA
Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)
- Status
- COMPLETED
- Phase
- NA
Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Intermittent Selumetinib for Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.
- Status
- TERMINATED
- Phase
- PHASE1
A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Multicentre Evaluating the Effectiveness and Toxicity Sorafenib (Nexavar®) in Adult Patients With Uveal Melanoma and Metastatic Dissemination
- Status
- COMPLETED
- Phase
- PHASE2
TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes
- Status
- COMPLETED
- Phase
- N/A